Regarding the potential buyout price of $30/share, wouldn't that be "ready to go" price?
meaning: phase 3 done, FDA approval etc.?
If RAC intends to sell prior to above would it not be reasonable to expect less than $30?
- Forums
- ASX - By Stock
- RAC
- Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett, page-66
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.48 |
Change
0.010(0.68%) |
Mkt cap ! $249.7M |
Open | High | Low | Value | Volume |
$1.48 | $1.50 | $1.46 | $65.07K | 44.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 336 | $1.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.50 | 7345 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5511 | 1.485 |
1 | 2500 | 1.480 |
1 | 1400 | 1.475 |
1 | 9188 | 1.470 |
1 | 1800 | 1.465 |
Price($) | Vol. | No. |
---|---|---|
1.510 | 5465 | 1 |
1.515 | 2553 | 1 |
1.520 | 1600 | 1 |
1.525 | 1000 | 1 |
1.535 | 2285 | 1 |
Last trade - 13.18pm 13/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online